# Ebselen as an add-on Treatment in Hypo/Mania

> **NCT03013400** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 60 (actual)

## Conditions studied

- Bipolar Disorder
- Bipolar Disorder, Manic

## Interventions

- **DRUG:** Ebselen
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03013400
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2019-07-09
- **Final completion:** 2019-07-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03013400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03013400, "Ebselen as an add-on Treatment in Hypo/Mania". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03013400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*